These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9201659)
21. Endocrine therapy of endometrial cancer. Lentz SS Cancer Treat Res; 1998; 94():89-106. PubMed ID: 9587684 [No Abstract] [Full Text] [Related]
22. Breast cancer prevention by antiestrogens. Osborne MP Ann N Y Acad Sci; 1999; 889():146-51. PubMed ID: 10668491 [TBL] [Abstract][Full Text] [Related]
24. Tamoxifen and beyond. Harv Womens Health Watch; 1998 Jun; 5(10):1. PubMed ID: 9663008 [No Abstract] [Full Text] [Related]
25. Tamoxifen in cancer therapy: minireview. Novotny L; Rauko P; Vachálková A; Peterson-Biggs M Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680 [TBL] [Abstract][Full Text] [Related]
26. SERMs: the benefits of estrogen without the risks? Cole RC; Flaws JA; Bush TL J Womens Health; 1998 Dec; 7(10):1187-9. PubMed ID: 9929850 [No Abstract] [Full Text] [Related]
27. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236 [TBL] [Abstract][Full Text] [Related]
28. [Tamoxifen and breast cancer: is everything known already?]. Marchetti P; Porzio G; Trapasso T; Baldi PL; Ficorella C Tumori; 1998; 84(6):A1-5. PubMed ID: 10080686 [No Abstract] [Full Text] [Related]
29. Tamoxifen. 'A big deal,' but a complex hand to play. Marshall E Science; 1998 Apr; 280(5361):196. PubMed ID: 9565527 [No Abstract] [Full Text] [Related]
30. Tamoxifen for breast cancer prevention. Force RW J Fam Pract; 1998 Nov; 47(5):336-7. PubMed ID: 9834765 [No Abstract] [Full Text] [Related]
31. Managing menopause after breast cancer: balancing risks and benefits. Moore HC Cleve Clin J Med; 2001 Mar; 68(3):243-8. PubMed ID: 11263852 [TBL] [Abstract][Full Text] [Related]
32. Tamoxifen in postmenopausal women a safety perspective. Robinson E; Kimmick GG; Muss HB Drugs Aging; 1996 May; 8(5):329-37. PubMed ID: 8935395 [TBL] [Abstract][Full Text] [Related]
33. Tamoxifen and the endometrium. Barakat RR Cancer Treat Res; 1998; 94():195-207. PubMed ID: 9587689 [No Abstract] [Full Text] [Related]
34. Gonadal hormone substitutes: effects on the cardiovascular system. Clarkson TB; Cline JM; Williams JK; Anthony MS Osteoporos Int; 1997; 7 Suppl 1():S43-51. PubMed ID: 9205646 [No Abstract] [Full Text] [Related]
35. [Prevention of breast cancer using tamoxifen]. Foidart JM; Colin C; Lifrange E Rev Med Liege; 1998 Apr; 53(4):225-6. PubMed ID: 9641022 [No Abstract] [Full Text] [Related]
36. Prospects for the primary prevention of breast cancer. Bernstein L; Ross RK; Henderson BE Am J Epidemiol; 1992 Jan; 135(2):142-52. PubMed ID: 1311141 [TBL] [Abstract][Full Text] [Related]
37. [Hormone therapy and breast cancer: a review]. Lucchi-Angellier E Rev Med Interne; 2001 Dec; 22(12):1213-24. PubMed ID: 11794892 [TBL] [Abstract][Full Text] [Related]
39. Raloxifene and its role in breast cancer prevention. Eng-Wong J; Zujewski JA Expert Rev Anticancer Ther; 2004 Aug; 4(4):523-32. PubMed ID: 15270657 [TBL] [Abstract][Full Text] [Related]
40. Tamoxifen for breast cancer prevention. Jpn J Clin Oncol; 1998 Dec; 28(12):775-6. PubMed ID: 9879301 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]